Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Journal of Biopharmaceutical Statistics|July 16, 2019
The i3+3 design for phase I clinical trialsMeizi Liu, Sue-Jane Wang, Yuan JiJournal of Biopharmaceutical Statistics|August 24, 2022
PMED: Optimal Bayesian Platform Trial Design with Multiple EndpointsTian He, Rachael Liu, Meizi Liu, et al.Statistics in Medicine|February 8, 2025
DOD-SSR: An Adaptive Seamless Phase II/III Design With Dose Optimization Decision and Sample Size Re-estimationMeizi Liu, Jianchang Lin, Yefei Zhang, et al.Statistics in Medicine|October 20, 2023
BEATS: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpointsDehua Bi, Meizi Liu, Jianchang Lin, et al.Biomedicines|August 6, 2021
Sevoflurane and Desflurane Exposures Following Aneurysmal Subarachnoid Hemorrhage Confer Multifaceted Protection against Delayed Cerebral IschemiaKeshav Jayaraman, Meizi Liu, Gregory J Zipfel, et al.Statistics in Medicine|June 14, 2021
Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical dataMeizi Liu, Veronica Bunn, Bradley Hupf, et al.Oral Health & Preventive Dentistry|December 12, 2024
Correlation Analysis Between Prognostic Nutritional Index Trajectory Categories and Radiotherapy-induced Severe Oral Mucositis in Head and Neck Cancer Patients Undergoing RadiotherapyMeizi Liu, Fei Gao, Ran An, et al.Journal of Hazardous Materials|October 4, 2023
Flow cytometry-based high-throughput screening of synthetic peptides for palladium adsorptionLing Tan, Meizi Liu, Lixian Wang, et al.Frontiers in Oncology|May 8, 2023
Oral health behavior and oral health service utilization among cancer patients in China: A multicenter cross-sectional studyRan An, Zitong Wu, Meizi Liu, et al.Journal of Biopharmaceutical Statistics|March 12, 2024
DOD-Combo: Bayesian dose finding design in combination trials with meta-analytic-predictive priorKai Chen, Yunqi Zhao, Meizi Liu, et al.Pageof 5